MarketsNotableConfirmed
10.0
BASF raises 2026 EBITDA guidance citing improved operating outlook
Dagens IndustriLO·DE·3 days ago
MarketsConfirmedMedium
9.4
Johnson & Johnson raises FY2026 guidance following Q2 earnings beat
Johnson & Johnson increased its full-year financial projections after Q2 sales exceeded expectations, primarily supported by strong demand for its oncology portfolio. The company's upward revision signals sustained growth in its pharmaceutical segment despite broader market volatility.
Score Breakdown
Mosaic Score9.4
Confidence0.9
Significance0.5
Source credibility0.5
Intelligence Tags
Locations
New Brunswick
Entities
country
Related signals
8 foundMarketsNotableConfirmedDeveloping
10.0
Netflix shares decline in after-hours trading following Q2 revenue report
AftenpostenLO·US·about 18 hours ago
MarketsSingle-source
2.1
Boehringer Ingelheim reports 16% H1 growth driven by Jardiance sales
Börsen-Zeitung·DE · US·3 days ago
MarketsSingle-source
2.1
Camurus reports Q2 2026 operating profit of 293 million SEK
Dagens IndustriLO·SE·3 days ago
MarketsSingle-source
2.1
Johnson & Johnson reports Q2 2026 adjusted EPS of $2.90
Dagens IndustriLO·US·2 days ago
MarketsNotableConfirmedDeveloping
10.0
China's state-owned airlines project increased H1 losses citing elevated fuel costs
Nikkei Asia·CN·3 days ago
MarketsNotableConfirmedDeveloping
10.0
Netflix faces earnings volatility following significant market capitalization decline
Irish IndependentLO·US·about 18 hours ago
MarketsNotableConfirmed
10.0
Major US banks report record H1 2026 profits driven by trading revenue
ExpansiónLO·US·3 days ago